TransMedics at canaccord growth conference: kidney push, margin trade-offs — See source for full details.
$TMDX
Price history, market instrument context, member research, and related headlines in one place.
TMDX key statistics
TransMedics Group, Inc. (TMDX) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $76.52, up $1.00 (1.32%) from the previous close of $75.52. It has traded between $74.86 and $77.34 in the latest session. Over the past year it has ranged from $60.11 to $156.00, leaving it in the lower quarter of its 52-week range (17%). Reported volume for the session was 1.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Related news
TransMedics Q2 2026 slides: revenue rises 21%, margins compress — See source for full details.